{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:53:10Z","timestamp":1789012390311,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson&apos;s Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.redox.2019.101377","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T20:43:14Z","timestamp":1573245794000},"page":"101377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["A functionalized hydroxydopamine quinone links thiol modification to neuronal cell death"],"prefix":"10.1016","volume":"28","author":[{"given":"Ali","family":"Farzam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Chohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Strmiskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Pezacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"\u00d6zcelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2019.101377_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3928\/0098-9134-20050601-11","article-title":"Caring for family with Alzheimer's disease and Parkinson's disease: needs, challenges and satisfaction","volume":"31","author":"Habermann","year":"2005","journal-title":"J. Gerontol. Nurs."},{"key":"10.1016\/j.redox.2019.101377_bib2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3233\/JAD-160484","article-title":"Alzheimer's and Parkinson's diseases: expected economic impact on europe-A call for a uniform European strategy","volume":"54","author":"Maresova","year":"2016","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.redox.2019.101377_bib3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1474-4422(15)00092-7","article-title":"Dementia in western Europe: epidemiological evidence and implications for policy making","volume":"15","author":"Wu","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.redox.2019.101377_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.redox.2019.101377_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.redox.2019.101377_bib6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson's disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2019.101377_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuron.2014.11.027","article-title":"Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on alpha-synuclein","volume":"85","author":"Dhungel","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.redox.2019.101377_bib8","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson's disease: from monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2019.101377_bib9","doi-asserted-by":"crossref","first-page":"134316","DOI":"10.1016\/j.neulet.2019.134316","article-title":"Alpha-synuclein pathology in Parkinson's disease and related alpha-synucleinopathies","author":"Henderson","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.redox.2019.101377_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","article-title":"The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy","volume":"920","author":"Spillantini","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.redox.2019.101377_bib11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/acschemneuro.7b00034","article-title":"Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson's disease?","volume":"8","author":"Herrera","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.redox.2019.101377_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.redox.2019.101377_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1515\/BC.2009.033","article-title":"Glutathione dysregulation and the etiology and progression of human diseases","volume":"390","author":"Ballatori","year":"2009","journal-title":"Biol. Chem."},{"key":"10.1016\/j.redox.2019.101377_bib14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1089\/ars.2017.7132","article-title":"Glutathione, glutaredoxins, and iron","volume":"27","author":"Berndt","year":"2017","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2019.101377_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bcp.2017.12.001","article-title":"Dopamine promotes cellular iron accumulation and oxidative stress responses in macrophages","volume":"148","author":"Dichtl","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2019.101377_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1471-4159.2002.01013.x","article-title":"Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease","volume":"82","author":"Hirrlinger","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2019.101377_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2017.04.035","article-title":"Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease","volume":"378","author":"Costa-Mallen","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.redox.2019.101377_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","article-title":"Glutathione metabolism and Parkinson's disease","volume":"62","author":"Smeyne","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101377_bib19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.redox.2019.101377_bib20","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1002\/anie.201811122","article-title":"Dopamine, oxidative stress and protein-quinone modifications in Parkinson's and other neurodegenerative diseases","volume":"58","author":"Monzani","year":"2019","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.redox.2019.101377_bib21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/acschemneuro.8b00454","article-title":"Impact of dopamine oxidation on dopaminergic neurodegeneration","volume":"10","author":"Zhang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.redox.2019.101377_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.redox.2019.101377_bib23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1096\/fj.04-3437fje","article-title":"Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway","volume":"19","author":"Cappai","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.redox.2019.101377_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3858\/emm.2011.43.4.026","article-title":"Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers","volume":"43","author":"Lee","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.redox.2019.101377_bib25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.redox.2018.01.008","article-title":"13 reasons why the brain is susceptible to oxidative stress","volume":"15","author":"Cobley","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101377_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson's disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.redox.2019.101377_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbadis.2010.06.006","article-title":"Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease","volume":"1802","author":"Bisaglia","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101377_bib28","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/jnc.12686","article-title":"Protective and toxic roles of dopamine in Parkinson's disease","volume":"129","author":"Segura-Aguilar","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2019.101377_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm00223a008","article-title":"Potential oxidative pathways of brain catecholamines","volume":"19","author":"Tse","year":"1976","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2019.101377_bib30","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101377_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-0749.1993.tb00612.x","article-title":"Role of melanin as a scavenger of active oxygen species","volume":"6","author":"Bustamante","year":"1993","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.redox.2019.101377_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.redox.2019.101377_bib33","doi-asserted-by":"crossref","first-page":"17567","DOI":"10.1073\/pnas.0808768105","article-title":"New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals","volume":"105","author":"Zecca","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101377_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.redox.2019.101377_bib35","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/S0021-9258(19)42751-8","article-title":"The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents","volume":"249","author":"Cohen","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101377_bib36","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/BF01946168","article-title":"In vivo generation of hydrogen peroxide from 6-hydroxydopamine","volume":"28","author":"Heikkila","year":"1972","journal-title":"Experientia"},{"key":"10.1016\/j.redox.2019.101377_bib37","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1021\/jm00006a010","article-title":"Generation of the neurotoxin 6-hydroxydopamine by peroxidase\/H2O2 oxidation of dopamine","volume":"38","author":"Napolitano","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2019.101377_bib38","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/jm970099t","article-title":"Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson's disease","volume":"40","author":"Pezzella","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2019.101377_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-1-61779-536-7_30","article-title":"A 6-hydroxydopamine in vivo model of Parkinson's disease","volume":"846","author":"Mercanti","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.redox.2019.101377_bib40","article-title":"6-hydroxydopamine (6-OHDA) oxidative stress assay for observing dopaminergic neuron loss in Caenorhabditis elegans","volume":"8","author":"Offenburger","year":"2018","journal-title":"Bio Protoc."},{"key":"10.1016\/j.redox.2019.101377_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.redox.2019.101377_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biom9050175","article-title":"Development of a competition-binding assay to determine binding affinity of molecules to neuromelanin via fluorescence spectroscopy","volume":"9","author":"Fink","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.redox.2019.101377_bib43","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1046\/j.1471-4159.2000.0741605.x","article-title":"Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease","volume":"74","author":"Soto-Otero","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2019.101377_bib44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.freeradbiomed.2013.06.030","article-title":"Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4","volume":"65","author":"Hauser","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101377_bib45","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1046\/j.1471-4159.1998.71052112.x","article-title":"Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species","volume":"71","author":"Spencer","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2019.101377_bib46","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nbd.2007.11.007","article-title":"Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease","volume":"29","author":"Van Laar","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2019.101377_bib47","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1046\/j.1471-4159.2001.00125.x","article-title":"Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter","volume":"76","author":"Whitehead","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2019.101377_bib48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F","article-title":"Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase","volume":"54","author":"Xu","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.redox.2019.101377_bib49","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1021\/bc900405q","article-title":"Chemical modification of M13 bacteriophage and its application in cancer cell imaging","volume":"21","author":"Li","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.redox.2019.101377_bib50","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1021\/ol035135z","article-title":"Practical synthetic route to functionalized rhodamine dyes","volume":"5","author":"Nguyen","year":"2003","journal-title":"Org. Lett."},{"key":"10.1016\/j.redox.2019.101377_bib51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/ja907716f","article-title":"Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities","volume":"132","author":"Yang","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.redox.2019.101377_bib52","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/acsinfecdis.6b00098","article-title":"6-Hydroxydopamine inhibits the hepatitis C virus through alkylation of host and viral proteins and the induction of oxidative stress","volume":"2","author":"Lafreniere","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.redox.2019.101377_bib53","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2019.101377_bib54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jmb.2010.12.039","article-title":"Two endoplasmic reticulum PDI peroxidases increase the efficiency of the use of peroxide during disulfide bond formation","volume":"406","author":"Nguyen","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.redox.2019.101377_bib55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/152308603768295096","article-title":"Defining the domain boundaries of the human protein disulfide isomerases","volume":"5","author":"Alanen","year":"2003","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2019.101377_bib56","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1021\/acschemneuro.9b00301","article-title":"Small molecule inhibition of protein disulfide isomerase in neuroblastoma cells induces an oxidative stress response and apoptosis pathways","volume":"10","author":"Ozcelik","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.redox.2019.101377_bib57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pep.2005.02.014","article-title":"A new method for purification of recombinant human alpha-synuclein in Escherichia coli","volume":"42","author":"Huang","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.redox.2019.101377_bib58","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.freeradbiomed.2017.04.367","article-title":"Challenges in the evaluation of thiol-reactive inhibitors of human protein disulfide Isomerase","volume":"108","author":"Foster","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101377_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BJ20050770","article-title":"A direct, continuous, sensitive assay for protein disulphide-isomerase based on fluorescence self-quenching","volume":"391","author":"Raturi","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2019.101377_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/9780470559277.ch090138","article-title":"Activity-Based protein profiling (ABPP) and click chemistry (CC)-ABPP by MudPIT mass spectrometry","volume":"1","author":"Speers","year":"2009","journal-title":"Curr. Protoc. Chem. Biol."},{"key":"10.1016\/j.redox.2019.101377_bib61","doi-asserted-by":"crossref","first-page":"W305","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene Suite for gene list enrichment analysis and candidate gene prioritization","volume":"37","author":"Chen","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.redox.2019.101377_bib62","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.redox.2019.101377_bib63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson's disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.redox.2019.101377_bib64","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1039\/C5CS90060C","article-title":"Correction: developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation","volume":"44","author":"Koniev","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.redox.2019.101377_bib65","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1039\/C5CS00048C","article-title":"Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation","volume":"44","author":"Koniev","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.redox.2019.101377_bib66","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1111\/febs.13909","article-title":"The extreme hyper-reactivity of selected cysteines drives hierarchical disulfide bond formation in serum albumin","volume":"283","author":"Bocedi","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.redox.2019.101377_bib67","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1471-4159.2001.00044.x","article-title":"Regulation of the tyrosine hydroxylase and dopamine beta-hydroxylase genes by the transcription factor AP-2","volume":"76","author":"Kim","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2019.101377_bib68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","article-title":"Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology","volume":"1078","author":"Kovalevich","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.redox.2019.101377_bib69","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1021\/acschemneuro.6b00164","article-title":"Interrogating the molecular basis for substrate recognition in serotonin and dopamine transporters with high-affinity substrate-based bivalent ligands","volume":"7","author":"Andersen","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.redox.2019.101377_bib70","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.chembiol.2013.03.014","article-title":"Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication","volume":"20","author":"Nasheri","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.redox.2019.101377_bib71","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-6-2","article-title":"6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death","volume":"6","author":"Bernstein","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.redox.2019.101377_bib72","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1046\/j.1471-4159.1995.64041703.x","article-title":"Free radical-generated neurotoxicity of 6-hydroxydopamine","volume":"64","author":"Kumar","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2019.101377_bib73","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jnr.20382","article-title":"p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly","volume":"79","author":"Izumi","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.redox.2019.101377_bib74","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12640-013-9382-7","article-title":"One-electron reduction of 6-hydroxydopamine quinone is essential in 6-hydroxydopamine neurotoxicity","volume":"24","author":"Villa","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.redox.2019.101377_bib75","doi-asserted-by":"crossref","first-page":"29586","DOI":"10.1074\/jbc.M113.467845","article-title":"Dynamic regulation of Ero1alpha and peroxiredoxin 4 localization in the secretory pathway","volume":"288","author":"Kakihana","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101377_bib76","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20130030","article-title":"Hyperoxidized peroxiredoxin 2 interacts with the protein disulfide- isomerase ERp46","volume":"453","author":"Pace","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2019.101377_bib77","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1038\/srep02456","article-title":"Synergistic cooperation of PDI family members in peroxiredoxin 4-driven oxidative protein folding","volume":"3","author":"Sato","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2019.101377_bib78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fchem.2014.00070","article-title":"Protein disulfide isomerase a multifunctional protein with multiple physiological roles","volume":"2","author":"Ali Khan","year":"2014","journal-title":"Front. Chem."},{"key":"10.1016\/j.redox.2019.101377_bib79","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1089\/ars.2009.2466","article-title":"Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation","volume":"11","author":"Hatahet","year":"2009","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2019.101377_bib80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.abb.2016.11.007","article-title":"Protein disulfide isomerases: redox connections in and out of the endoplasmic reticulum","volume":"617","author":"Soares Moretti","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.redox.2019.101377_bib81","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2019.101377_bib82","first-page":"80","article-title":"The unfolded protein response and the role of protein disulfide isomerase in neurodegeneration","volume":"3","author":"Perri","year":"2015","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.redox.2019.101377_bib83","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archneurol.2007.56","article-title":"Protein misfolding and neurodegeneration","volume":"65","author":"Soto","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.redox.2019.101377_bib84","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1471-4159.2007.04699.x","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons","volume":"103","author":"Rodriguez-Pallares","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2019.101377_bib85","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.freeradbiomed.2006.12.004","article-title":"Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action","volume":"42","author":"Saito","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101377_bib86","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm1314","article-title":"Dopamine covalently modifies and functionally inactivates parkin","volume":"11","author":"LaVoie","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2019.101377_bib87","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/bi9018658","article-title":"Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease","volume":"49","author":"Sabens","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2019.101377_bib88","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4957","article-title":"N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae","volume":"6","author":"Benvenutti","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.redox.2019.101377_bib89","first-page":"155","article-title":"Metallothionein isoforms provide neuroprotection against 6-hydroxydopamine-generated hydroxyl radicals and superoxide anions","volume":"41","author":"Ebadi","year":"1998","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"10.1016\/j.redox.2019.101377_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.taap.2016.02.010","article-title":"Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo","volume":"296","author":"Nouraei","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.redox.2019.101377_bib91","doi-asserted-by":"crossref","first-page":"C81","DOI":"10.1152\/ajpcell.00281.2011","article-title":"Hydrogen sulfide protects SH-SY5Y cells against 6-hydroxydopamine-induced endoplasmic reticulum stress","volume":"303","author":"Xie","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.redox.2019.101377_bib92","article-title":"Cysteine, glutathione, and thiol redox balance in astrocytes","volume":"6","author":"McBean","year":"2017","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.redox.2019.101377_bib93","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.redox.2015.04.004","article-title":"Thiol redox homeostasis in neurodegenerative disease","volume":"5","author":"McBean","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2019.101377_bib94","doi-asserted-by":"crossref","first-page":"16793","DOI":"10.1073\/pnas.0707090104","article-title":"Copper-free click chemistry for dynamic in vivo imaging","volume":"104","author":"Baskin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101377_bib95","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1073\/pnas.0911116107","article-title":"Copper-free click chemistry in living animals","volume":"107","author":"Chang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101377_bib96","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.1021\/ja803086r","article-title":"Second-generation difluorinated cyclooctynes for copper-free click chemistry","volume":"130","author":"Codelli","year":"2008","journal-title":"J. Am. Chem. Soc."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231719308973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231719308973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:12:45Z","timestamp":1761977565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231719308973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":96,"alternative-id":["S2213231719308973"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2019.101377","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A functionalized hydroxydopamine quinone links thiol modification to neuronal cell death","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2019.101377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101377"}}